Zibar, K., Knežević Ćuća, J., Blaslov, K., Bulum, T. & Smirčić Duvnjak, L. (2015). Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls. Annals of Clinical Biochemistry, 52. (2), 220-225. doi: 10.1177/0004563214544709
Zibar, Karin, et al. "Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls." Annals of Clinical Biochemistry, vol. 52, no. 2, 2015, pp. 220-225. https://doi.org/10.1177/0004563214544709
Zibar, Karin, Jadranka Knežević Ćuća, Kristina Blaslov, Tomislav Bulum and Lea Smirčić Duvnjak. "Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls." Annals of Clinical Biochemistry 52, no. 2 (2015): 220-225. https://doi.org/10.1177/0004563214544709
Zibar, K., et al. (2015) 'Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls', Annals of Clinical Biochemistry, 52(2), pp. 220-225. doi: 10.1177/0004563214544709
Zibar K, Knežević Ćuća J, Blaslov K, Bulum T, Smirčić Duvnjak L. Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls. Annals of Clinical Biochemistry [Internet]. 2015 [cited 2024 November 10];52(2):220-225. doi: 10.1177/0004563214544709
K. Zibar, J. Knežević Ćuća, K. Blaslov, T. Bulum and L. Smirčić Duvnjak, "Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls", Annals of Clinical Biochemistry, vol. 52, no. 2, pp. 220-225, 2015. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:613406. [Accessed: 10 November 2024]